Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024


Tokyo, Japan and Cambridge, UK, 1 November 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – provides an update on operational activities and reports its consolidated results for the third quarter and nine months ended on 30 September 2024. The full report can be viewed here.

Original post:
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024

Related Posts